Cholesterol and Cognitive Performance in Normal Controls and the Influence of Elective Statin Use after Conversion to Mild Cognitive Impairment: Results in a Clinical Trial Cohort

Publisher： Karger

E-ISSN： 1660-2862|7|1-3|183-186

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.7, Iss.1-3, 2010-03, pp. : 183-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cerebrospinal Fluid Biomarkers Predict Clinical Evolution in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment

By  

Neurodegenerative Diseases, Vol. 16, Iss. 1-2, 2016-0 ,pp. : 69-76

Karger

Access to resources Recommend Favorite

Hippocampal Drebrin Loss in Mild Cognitive Impairment

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-02 ,pp. : 216-219

Karger

Access to resources Recommend Favorite

Spatial Navigation and APOE in Amnestic Mild Cognitive Impairment

By  

Neurodegenerative Diseases, Vol. 8, Iss. 4, 2010-12 ,pp. : 169-177

Karger

Access to resources Recommend Favorite

Effectiveness of Nonpharmacological Approaches in Patients with Mild Cognitive Impairment

By  

Neurodegenerative Diseases, Vol. 8, Iss. 3, 2010-12 ,pp. : 138-145

Karger

Access to resources Recommend Favorite

Plasma Urate and Progression of Mild Cognitive Impairment

By  

Neurodegenerative Diseases, Vol. 6, Iss. 1-2, 2008-11 ,pp. : 23-28

Karger

Access to resources Recommend Favorite